NEW YORK (GenomeWeb) – Roche said today that sales for its Diagnostics division grew 7 percent in the first nine months of 2016, driven primarily by immunodiagnostic products.

In total, the Swiss pharmaceutical and diagnostics company booked CHF 37.51 billion ($38.03 billion) in sales for the first three quarters, a 6 percent increase over sales of CHF 35.53 billion during the same period in 2015. On a constant currency basis, sales grew 4 percent in the first nine months of 2016.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Feb
27

In this webinar, Jill Viles, an Iowa mother with no clinical training, shares her story of how she self-diagnosed her rare condition, a muscle-wasting disease caused by a mutation in the LMNA gene. She will also discuss how she discovered that a mutation in the same gene is the underlying cause for the excess muscle phenotype exhibited by Canadian Olympic hurdler Priscilla Lopes-Schliep. 

Mar
13

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.

Apr
03

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.